首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1922801

日本網路藥局市場規模、佔有率、趨勢及預測（依藥品類型、產品類型、平台、支付方式及地區分類，2026-2034年）

Japan E-Pharmacy Market Size, Share, Trends and Forecast by Drug Type, Product Type, Platform, Payment Method, and Region, 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

日本網路藥局市場規模在2025年達到71億美元。 IMARC Group預測，到2034年，該市場規模將達到205億美元，2026年至2034年的複合年成長率（CAGR）為12.43%。推動市場顯著成長的因素包括人口老化、慢性疾病患者數量增加、數位技術的廣泛應用以及監管支持。此外，對遠距處方箋和便利性的需求不斷成長，也推動了對基於應用程式的平台、處方箋服務和線上醫療整合的投資。

日本線上藥局市場的發展趨勢：

放寬對網路藥品銷售的監管

日本的法規環境正逐步向數位化醫療轉型，為線上藥局產業的成長創造了空間。例如，繼Google宣布政策調整後，日本於2024年12月宣布計畫允許獲得許可的線上藥局和遠端醫療服務提供者從2025年1月起開始宣傳處方藥服務。服務提供者必須獲得厚生勞動省的許可或LegitScript認證，並接受Google的額外檢驗。逐步放寬對非處方藥和部分處方藥線上銷售的監管，是推動日本網路藥局市場成長的主要動力。監管調整後，藥局現在可以提供線上諮詢、遠端處方箋處理和直接送貨上門服務。這些變化鼓勵了現有連鎖藥局和新參與企業投資於數位基礎設施和服務整合。透過允許藥品分發和取得方式柔軟性，法規結構與數位化醫療和消費者便利性的整體趨勢相契合。預計這一環境將進一步發展，促進市場參與企業之間的競爭和創新。這項轉變也反映了政府在不影響安全性和合規性的前提下，實現藥品取得途徑現代化的意圖。隨著這些變革的逐步落實，很可能會對日本的線上藥局市佔率產生直接影響。

高齡化社會與慢性病管理

日本人口老化正顯著影響著醫療服務的提供方式。這種人口結構的變化推動了對便利居家醫療解決方案的需求，尤其對於需要管理高血壓、糖尿病和心血管疾病等慢性病的人。據報道，目前日本超過十分之一的人口年齡在80歲及以上，約有三分之一的人口（約3,623萬人）年齡在65歲及以上。日本仍然是世界上老化程度最高的國家之一。網路藥局平台透過提供簡化的處方箋續藥服務、用藥提醒和客製化的宅配服務來滿足這項需求。許多服務都最佳化了用戶體驗，例如語音引導應用程式、放大的介面文字以及與看護者整合的帳戶。這些平台不僅減少了老年人去藥局的次數，還有助於維持治療的連續性，這對慢性病管理至關重要。隨著老年人數位素養的提高和支持系統的完善，預計網路藥局的普及率將進一步擴大。這種人口結構的變化是影響日本網路藥局市場前景的關鍵因素。

本報告解答的關鍵問題

日本網路藥局市場目前發展狀況如何？未來幾年又將如何發展？
日本網路藥局市場按藥品類型分類的市場組成是什麼？
日本網路藥局市場依產品類型分類的組成是怎樣的？
日本線上藥局市場按平台分類的市佔率構成是什麼？
日本線上藥局市場按支付方式是如何細分的？
日本線上藥局市場按地區分類的市場組成是什麼？
請介紹一下日本線上藥局市場價值鏈的各個環節。
日本線上藥局市場的主要促進因素和挑戰是什麼？
日本線上藥局市場的結構是怎樣的？主要參與者有哪些？
日本網路藥局市場競爭有多激烈？

The Japan e-pharmacy market size reached USD 7.10 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 20.50 Billion by 2034 , exhibiting a growth rate (CAGR) of 12.43% during 2026-2034 . The market is experiencing significant growth, driven by an aging population, growing chronic illness cases, digital adoption, and regulatory support. Moreover, increased demand for remote prescriptions and convenience is encouraging investments in app-based platforms, prescription services, and online healthcare integration.

JAPAN E-PHARMACY MARKET TRENDS:

Regulatory Relaxation for Online Drug Sales

Japan's regulatory environment has steadily become more supportive of digital healthcare, creating room for growth in the online pharmacy sector. For instance, in December 2024, Japan announced its plans to permit licensed online pharmacies and telemedicine providers to advertise prescription drug services starting January 2025, following a policy shift announced by Google. Providers must secure MHLW licensing or LegitScript certification and undergo additional Google verification. The gradual relaxation of rules around the online sale of over-the-counter and certain prescription drugs has been a key driver behind Japan e-pharmacy market growth. Regulatory adjustments have enabled pharmacies to offer digital consultations, process prescriptions remotely, and deliver medications directly to consumers. These shifts have encouraged both established pharmacy chains and new entrants to invest in digital infrastructure and service integration. By allowing more flexibility in how medications are dispensed and accessed, the regulatory framework is aligning with broader trends in digital health and consumer convenience. This environment is expected to further evolve, enabling stronger competition and innovation among market participants. This transformation also reflects the government's intent to modernize pharmaceutical access without compromising safety or compliance. As these changes take root, they are likely to have a direct impact on Japan e-pharmacy market share.

To get more information on this market Request Sample

Rising Aging Population and Chronic Disease Management

Japan's aging population is significantly influencing how healthcare services are delivered. This demographic shift has increased demand for accessible, home-based medication solutions, particularly for those managing chronic conditions like hypertension, diabetes, and cardiovascular diseases. According to reports, more than 1 in 10 people in Japan are now aged 80 or older, with nearly a third of the population (approximately 36.23 million) over 65. Japan's demographic remains the oldest globally. E-pharmacy platforms are stepping in to address this need by offering simplified prescription refill services, medication reminders, and home delivery tailored to elderly users. Many services are now optimized for ease of use, including voice-guided apps, larger interface text, and caregiver-linked accounts. These platforms not only reduce the need for physical visits to pharmacies but also support ongoing treatment adherence-critical in chronic disease management. As digital literacy improves among older adults and support systems around them strengthen, e-pharmacy adoption is expected to rise further. This demographic-driven shift is a central factor shaping the Japan e-pharmacy market outlook.

JAPAN E-PHARMACY MARKET SEGMENTATION:

Drug Type Insights:

Over the Counter (OTC) Drugs
Prescription Drugs
Over the Counter (OTC) Drugs
Prescription Drugs

Product Type Insights:

Access the comprehensive market breakdown Request Sample
Skin Care
Dental
Cold and Flu
Vitamins
Weight Loss
Others
Skin Care
Dental
Cold and Flu
Vitamins
Weight Loss
Others

Platform Insights:

App-Based
Web-Based
App-Based
Web-Based

Payment Method Insights:

Cash on Delivery
Online Payment
Cash on Delivery
Online Payment

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central /Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan e-pharmacy market performed so far and how will it perform in the coming years?
What is the breakup of the Japan e-pharmacy market on the basis of drug type?
What is the breakup of the Japan e-pharmacy market on the basis of product type?
What is the breakup of the Japan e-pharmacy market on the basis of platform?
What is the breakup of the Japan e-pharmacy market on the basis of payment method?
What is the breakup of the Japan e-pharmacy market on the basis of region?
What are the various stages in the value chain of the Japan e-pharmacy market?
What are the key driving factors and challenges in the Japan e-pharmacy?
What is the structure of the Japan e-pharmacy market and who are the key players?
What is the degree of competition in the Japan e-pharmacy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan E-Pharmacy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan E-Pharmacy Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan E-Pharmacy Market - Breakup by Drug Type

6.1 Over the Counter (OTC) Drugs
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Prescription Drugs
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan E-Pharmacy Market - Breakup by Product Type

7.1 Skin Care
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Dental
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Cold and Flu
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Vitamins
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Weight Loss
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2020-2025)
- 7.6.2 Market Forecast (2026-2034)

8 Japan E-Pharmacy Market - Breakup by Platform

8.1 App-Based
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Web-Based
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan E-Pharmacy Market - Breakup by Payment Method

9.1 Cash on Delivery
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Online Payment
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)

10 Japan E-Pharmacy Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Drug Type
- 10.1.4 Market Breakup by Product Type
- 10.1.5 Market Breakup by Platform
- 10.1.6 Market Breakup by Payment Method
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Drug Type
- 10.2.4 Market Breakup by Product Type
- 10.2.5 Market Breakup by Platform
- 10.2.6 Market Breakup by Payment Method
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Drug Type
- 10.3.4 Market Breakup by Product Type
- 10.3.5 Market Breakup by Platform
- 10.3.6 Market Breakup by Payment Method
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Drug Type
- 10.4.4 Market Breakup by Product Type
- 10.4.5 Market Breakup by Platform
- 10.4.6 Market Breakup by Payment Method
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Drug Type
- 10.5.4 Market Breakup by Product Type
- 10.5.5 Market Breakup by Platform
- 10.5.6 Market Breakup by Payment Method
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Drug Type
- 10.6.4 Market Breakup by Product Type
- 10.6.5 Market Breakup by Platform
- 10.6.6 Market Breakup by Payment Method
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Drug Type
- 10.7.4 Market Breakup by Product Type
- 10.7.5 Market Breakup by Platform
- 10.7.6 Market Breakup by Payment Method
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Drug Type
- 10.8.4 Market Breakup by Product Type
- 10.8.5 Market Breakup by Platform
- 10.8.6 Market Breakup by Payment Method
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan E-Pharmacy Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan E-Pharmacy Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis